The global market for T-Cell Immunotherapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for T-Cell Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell Immunotherapy.

The T-Cell Immunotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global T-Cell Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the T-Cell Immunotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of T-Cell Immunotherapy Market Report

Report Metric	Details
Report Name	T-Cell Immunotherapy Market
CAGR	5%
Segment by Type	CAR-T TCR TIL Therapies
Segment by Application	Stomach Cancer Lung Cancer Colorectal Cancer Esophagus Cancer Pancreatic Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Adaptimmune, Altor Bioscience Corporation, Cellectis, Juno Therapeutics, Kite Pharma, Novartis, Takara Bio, Unum Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of T-Cell Immunotherapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the T-Cell Immunotherapy Market report?

Ans: The main players in the T-Cell Immunotherapy Market are Adaptimmune, Altor Bioscience Corporation, Cellectis, Juno Therapeutics, Kite Pharma, Novartis, Takara Bio, Unum Therapeutics

What are the Application segmentation covered in the T-Cell Immunotherapy Market report?

Ans: The Applications covered in the T-Cell Immunotherapy Market report are Stomach Cancer, Lung Cancer, Colorectal Cancer, Esophagus Cancer, Pancreatic Cancer, Others

What are the Type segmentation covered in the T-Cell Immunotherapy Market report?

Ans: The Types covered in the T-Cell Immunotherapy Market report are CAR-T, TCR, TIL Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CAR-T

1.2.3 TCR

1.2.4 TIL Therapies

1.3 Market by Application

1.3.1 Global T-Cell Immunotherapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Stomach Cancer

1.3.3 Lung Cancer

1.3.4 Colorectal Cancer

1.3.5 Esophagus Cancer

1.3.6 Pancreatic Cancer

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global T-Cell Immunotherapy Market Perspective (2020-2031)

2.2 Global T-Cell Immunotherapy Growth Trends by Region

2.2.1 Global T-Cell Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 T-Cell Immunotherapy Historic Market Size by Region (2020-2025)

2.2.3 T-Cell Immunotherapy Forecasted Market Size by Region (2026-2031)

2.3 T-Cell Immunotherapy Market Dynamics

2.3.1 T-Cell Immunotherapy Industry Trends

2.3.2 T-Cell Immunotherapy Market Drivers

2.3.3 T-Cell Immunotherapy Market Challenges

2.3.4 T-Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top T-Cell Immunotherapy Players by Revenue

3.1.1 Global Top T-Cell Immunotherapy Players by Revenue (2020-2025)

3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2020-2025)

3.2 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by T-Cell Immunotherapy Revenue

3.4 Global T-Cell Immunotherapy Market Concentration Ratio

3.4.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2024

3.5 Global Key Players of T-Cell Immunotherapy Head office and Area Served

3.6 Global Key Players of T-Cell Immunotherapy, Product and Application

3.7 Global Key Players of T-Cell Immunotherapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 T-Cell Immunotherapy Breakdown Data by Type

4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2020-2025)

4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2026-2031)

5 T-Cell Immunotherapy Breakdown Data by Application

5.1 Global T-Cell Immunotherapy Historic Market Size by Application (2020-2025)

5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America T-Cell Immunotherapy Market Size (2020-2031)

6.2 North America T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America T-Cell Immunotherapy Market Size by Country (2020-2025)

6.4 North America T-Cell Immunotherapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe T-Cell Immunotherapy Market Size (2020-2031)

7.2 Europe T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe T-Cell Immunotherapy Market Size by Country (2020-2025)

7.4 Europe T-Cell Immunotherapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific T-Cell Immunotherapy Market Size (2020-2031)

8.2 Asia-Pacific T-Cell Immunotherapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2020-2025)

8.4 Asia-Pacific T-Cell Immunotherapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America T-Cell Immunotherapy Market Size (2020-2031)

9.2 Latin America T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America T-Cell Immunotherapy Market Size by Country (2020-2025)

9.4 Latin America T-Cell Immunotherapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa T-Cell Immunotherapy Market Size (2020-2031)

10.2 Middle East & Africa T-Cell Immunotherapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2020-2025)

10.4 Middle East & Africa T-Cell Immunotherapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Adaptimmune

11.1.1 Adaptimmune Company Details

11.1.2 Adaptimmune Business Overview

11.1.3 Adaptimmune T-Cell Immunotherapy Introduction

11.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2020-2025)

11.1.5 Adaptimmune Recent Development

11.2 Altor Bioscience Corporation

11.2.1 Altor Bioscience Corporation Company Details

11.2.2 Altor Bioscience Corporation Business Overview

11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction

11.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2020-2025)

11.2.5 Altor Bioscience Corporation Recent Development

11.3 Cellectis

11.3.1 Cellectis Company Details

11.3.2 Cellectis Business Overview

11.3.3 Cellectis T-Cell Immunotherapy Introduction

11.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2020-2025)

11.3.5 Cellectis Recent Development

11.4 Juno Therapeutics

11.4.1 Juno Therapeutics Company Details

11.4.2 Juno Therapeutics Business Overview

11.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction

11.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2020-2025)

11.4.5 Juno Therapeutics Recent Development

11.5 Kite Pharma

11.5.1 Kite Pharma Company Details

11.5.2 Kite Pharma Business Overview

11.5.3 Kite Pharma T-Cell Immunotherapy Introduction

11.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2020-2025)

11.5.5 Kite Pharma Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis T-Cell Immunotherapy Introduction

11.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Takara Bio

11.7.1 Takara Bio Company Details

11.7.2 Takara Bio Business Overview

11.7.3 Takara Bio T-Cell Immunotherapy Introduction

11.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2020-2025)

11.7.5 Takara Bio Recent Development

11.8 Unum Therapeutics

11.8.1 Unum Therapeutics Company Details

11.8.2 Unum Therapeutics Business Overview

11.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction

11.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2020-2025)

11.8.5 Unum Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Adaptimmune

Altor BioScience Corporation

List of Tables

Table 1. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CAR-T

Table 3. Key Players of TCR

Table 4. Key Players of TIL Therapies

Table 5. Global T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global T-Cell Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global T-Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global T-Cell Immunotherapy Market Share by Region (2020-2025)

Table 9. Global T-Cell Immunotherapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global T-Cell Immunotherapy Market Share by Region (2026-2031)

Table 11. T-Cell Immunotherapy Market Trends

Table 12. T-Cell Immunotherapy Market Drivers

Table 13. T-Cell Immunotherapy Market Challenges

Table 14. T-Cell Immunotherapy Market Restraints

Table 15. Global T-Cell Immunotherapy Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global T-Cell Immunotherapy Market Share by Players (2020-2025)

Table 17. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2024)

Table 18. Ranking of Global Top T-Cell Immunotherapy Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by T-Cell Immunotherapy Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of T-Cell Immunotherapy, Headquarters and Area Served

Table 21. Global Key Players of T-Cell Immunotherapy, Product and Application

Table 22. Global Key Players of T-Cell Immunotherapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global T-Cell Immunotherapy Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global T-Cell Immunotherapy Revenue Market Share by Type (2020-2025)

Table 26. Global T-Cell Immunotherapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global T-Cell Immunotherapy Revenue Market Share by Type (2026-2031)

Table 28. Global T-Cell Immunotherapy Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global T-Cell Immunotherapy Revenue Market Share by Application (2020-2025)

Table 30. Global T-Cell Immunotherapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global T-Cell Immunotherapy Revenue Market Share by Application (2026-2031)

Table 32. North America T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific T-Cell Immunotherapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific T-Cell Immunotherapy Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa T-Cell Immunotherapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa T-Cell Immunotherapy Market Size by Country (2026-2031) & (US$ Million)

Table 47. Adaptimmune Company Details

Table 48. Adaptimmune Business Overview

Table 49. Adaptimmune T-Cell Immunotherapy Product

Table 50. Adaptimmune Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 51. Adaptimmune Recent Development

Table 52. Altor Bioscience Corporation Company Details

Table 53. Altor Bioscience Corporation Business Overview

Table 54. Altor Bioscience Corporation T-Cell Immunotherapy Product

Table 55. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 56. Altor Bioscience Corporation Recent Development

Table 57. Cellectis Company Details

Table 58. Cellectis Business Overview

Table 59. Cellectis T-Cell Immunotherapy Product

Table 60. Cellectis Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 61. Cellectis Recent Development

Table 62. Juno Therapeutics Company Details

Table 63. Juno Therapeutics Business Overview

Table 64. Juno Therapeutics T-Cell Immunotherapy Product

Table 65. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 66. Juno Therapeutics Recent Development

Table 67. Kite Pharma Company Details

Table 68. Kite Pharma Business Overview

Table 69. Kite Pharma T-Cell Immunotherapy Product

Table 70. Kite Pharma Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 71. Kite Pharma Recent Development

Table 72. Novartis Company Details

Table 73. Novartis Business Overview

Table 74. Novartis T-Cell Immunotherapy Product

Table 75. Novartis Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 76. Novartis Recent Development

Table 77. Takara Bio Company Details

Table 78. Takara Bio Business Overview

Table 79. Takara Bio T-Cell Immunotherapy Product

Table 80. Takara Bio Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 81. Takara Bio Recent Development

Table 82. Unum Therapeutics Company Details

Table 83. Unum Therapeutics Business Overview

Table 84. Unum Therapeutics T-Cell Immunotherapy Product

Table 85. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2020-2025) & (US$ Million)

Table 86. Unum Therapeutics Recent Development

Table 87. Research Programs/Design for This Report

Table 88. Key Data Information from Secondary Sources

Table 89. Key Data Information from Primary Sources

Table 90. Authors List of This Report

List of Figures

Figure 1. T-Cell Immunotherapy Picture

Figure 2. Global T-Cell Immunotherapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global T-Cell Immunotherapy Market Share by Type: 2024 VS 2031

Figure 4. CAR-T Features

Figure 5. TCR Features

Figure 6. TIL Therapies Features

Figure 7. Global T-Cell Immunotherapy Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global T-Cell Immunotherapy Market Share by Application: 2024 VS 2031

Figure 9. Stomach Cancer Case Studies

Figure 10. Lung Cancer Case Studies

Figure 11. Colorectal Cancer Case Studies

Figure 12. Esophagus Cancer Case Studies

Figure 13. Pancreatic Cancer Case Studies

Figure 14. Others Case Studies

Figure 15. T-Cell Immunotherapy Report Years Considered

Figure 16. Global T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global T-Cell Immunotherapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global T-Cell Immunotherapy Market Share by Region: 2024 VS 2031

Figure 19. Global T-Cell Immunotherapy Market Share by Players in 2024

Figure 20. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2024

Figure 22. North America T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America T-Cell Immunotherapy Market Share by Country (2020-2031)

Figure 24. United States T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe T-Cell Immunotherapy Market Share by Country (2020-2031)

Figure 28. Germany T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific T-Cell Immunotherapy Market Share by Region (2020-2031)

Figure 36. China T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America T-Cell Immunotherapy Market Share by Country (2020-2031)

Figure 44. Mexico T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa T-Cell Immunotherapy Market Share by Country (2020-2031)

Figure 48. Turkey T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE T-Cell Immunotherapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)

Figure 52. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)

Figure 53. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)

Figure 54. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)

Figure 55. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)

Figure 57. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)

Figure 58. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Rabbit Anti-Mouse IgG Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32M14204

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Cell Therapy CMO Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20C14515

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Advanced Therapy Based on Gene Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-31E15068

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Anti-human Lambda Light Chains Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37M14325

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions